Articles with "fes pet" as a keyword



Photo from wikipedia

PET Imaging of Estrogen Receptors Using 18F-Based Radioligands.

Sign Up to like & get
recommendations!
Published in 2022 at "Methods in molecular biology"

DOI: 10.1007/978-1-0716-1920-9_9

Abstract: In vivo molecular imaging of estrogen receptor alpha (ER) can be performed via positron emission tomography (PET) using ER-specific radioligands, such as 16α-[18F]fluoro-17β-estradiol (18F-FES). 18F-FES is a radiopharmaceutical recently approved by the United States Food… read more here.

Keywords: fes pet; pet imaging; imaging estrogen; 18f fes ... See more keywords
Photo by jonasvincentbe from unsplash

18F-FES PET/CT for Characterization of Brain and Leptomeningeal Metastasis in Double Primary Cancer Patient.

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical nuclear medicine"

DOI: 10.1097/rlu.0000000000004197

Abstract: ABSTRACT The clinical value of 16α-18F-fluoro-17 β-estradiol (18F-FES) PET in breast cancer has been widely investigated because it can visualize estrogen receptor-expressing lesions. This relatively new radiotracer adds clinical values by characterization of metastasis in… read more here.

Keywords: 18f fes; fes pet; brain; metastasis double ... See more keywords
Photo from archive.org

FDG PET and FES PET Predict PFS on Endocrine Therapy—Letter

Sign Up to like & get
recommendations!
Published in 2018 at "Clinical Cancer Research"

DOI: 10.1158/1078-0432.ccr-17-2380

Abstract: With great interest, we read the article by Kurland and colleagues ([1][1]) that investigates the value of 18F-fluoroestradiol (FES) and 18F-fluorodeoxyglucose (FDG) PET for the prediction of progression-free survival (PFS) in 84 patients with advanced,… read more here.

Keywords: pfs; pet; fes pet; fdg pet ... See more keywords
Photo from wikipedia

Clinical Validity of 16α-[18F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.22.00400

Abstract: PURPOSE Determining the estrogen receptor (ER) status is essential in metastatic breast cancer (MBC) management. Whole-body ER imaging with 16α-[18F]fluoro-17β-estradiol positron emission tomography ([18F]FES-PET) is increasingly used for this purpose. To establish the clinical validity… read more here.

Keywords: metastasis; 18f fes; fes pet; status ... See more keywords
Photo from wikipedia

The clinical value of 18F-fluoroestradiol in assisting individualized treatment decision in dual primary malignancies.

Sign Up to like & get
recommendations!
Published in 2021 at "Quantitative imaging in medicine and surgery"

DOI: 10.21037/qims-20-1364

Abstract: Background For patients with previously diagnosed dual primary tumors, it is usually difficult to determine the diagnosis and treatment of stage IV recurrence. The study was to explore the influences of 18F-fluoroestradiol positron emission tomography/computed… read more here.

Keywords: fes pet; treatment; dual primary; 18f fluoroestradiol ... See more keywords
Photo from wikipedia

Chemotherapy Shows a Better Efficacy Than Endocrine Therapy in Metastatic Breast Cancer Patients with a Heterogeneous Estrogen Receptor Expression Assessed by 18F-FES PET

Sign Up to like & get
recommendations!
Published in 2022 at "Cancers"

DOI: 10.3390/cancers14143531

Abstract: Simple Summary About 10–20% of breast cancer patients have a heterogeneous estrogen receptor expression. The diagnosis and treatment strategy remains controversial in these patients, especially regarding the metastatic pattern. The aim of our study was… read more here.

Keywords: breast cancer; estrogen receptor; fes pet; 18f fes ... See more keywords
Photo from wikipedia

[18F]FES PET Resolves the Diagnostic Dilemma of COVID-19-Vaccine-Associated Hypermetabolic Lymphadenopathy in ER-Positive Breast Cancer

Sign Up to like & get
recommendations!
Published in 2023 at "Diagnostics"

DOI: 10.3390/diagnostics13111851

Abstract: Coronavirus disease (COVID-19) vaccination is known to cause a diagnostic dilemma due to false-positive findings on [18F]FDG PET in vaccine-associated hypermetabolic lymphadenopathy. We present two case reports of women with estrogen-receptor (ER)-positive cancer of the… read more here.

Keywords: 18f fes; breast; vaccine associated; fes pet ... See more keywords